Drug intelligence / Profile preview

aspirin + meloxicam

Development stage
Phase 1
Lead developer
Boehringer Ingelheim
Modality
Small Molecules
Administration
Oral
01

Overview

A combination of two nonsteroidal anti-inflammatory drugs (NSAIDs). Meloxicam is a prescription NSAID that selectively inhibits COX-2 enzymes, while aspirin (acetylsalicylic acid) is an NSAID that inhibits both COX-1 and COX-2 enzymes. When taken together, these medications can interact with each other. According to the search results, concurrent treatment with aspirin can increase plasma concentrations of meloxicam, raising the maximum plasma concentration (Cmax) by approximately 25% and the area under the plasma concentration-time curve (AUC) by 10%[3]. However, these differences were not considered clinically relevant, and no adjustments of meloxicam dose should be required when coadministered with aspirin[3]. Both medications are used to treat pain and inflammation, but they have different properties. Meloxicam is primarily used for osteoarthritis, rheumatoid arthritis, and juvenile rheumatoid arthritis[7]. Aspirin, besides its anti-inflammatory effects, also has antiplatelet properties that make it beneficial for preventing heart attacks and strokes, which meloxicam does not offer[6].

Other names
acetylsalicylic acid + meloxicamaspirin and meloxicam
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on aspirin + meloxicam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aspirin + meloxicam.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call